Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $56,150 | 23 | 61.8% |
| Consulting Fee | $16,516 | 5 | 18.2% |
| Travel and Lodging | $7,562 | 26 | 8.3% |
| Unspecified | $6,123 | 1 | 6.7% |
| Food and Beverage | $4,278 | 51 | 4.7% |
| Education | $196.28 | 3 | 0.2% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $52,101 | 58 | $0 (2023) |
| PFIZER INC. | $19,326 | 23 | $0 (2018) |
| Lilly USA, LLC | $6,461 | 9 | $0 (2022) |
| Eli Lilly and Company | $6,123 | 1 | $0 (2017) |
| Janssen Scientific Affairs, LLC | $4,932 | 6 | $0 (2018) |
| Fresenius Kabi USA, LLC | $610.00 | 1 | $0 (2023) |
| Janssen Biotech, Inc. | $380.04 | 5 | $0 (2024) |
| Medivators Inc. | $350.00 | 1 | $0 (2018) |
| Cook Medical LLC | $183.00 | 2 | $0 (2022) |
| Takeda Pharmaceuticals U.S.A., Inc. | $150.00 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $134.91 | 2 | Janssen Biotech, Inc. ($134.91) |
| 2023 | $997.71 | 6 | Fresenius Kabi USA, LLC ($610.00) |
| 2022 | $6,916 | 14 | Lilly USA, LLC ($6,461) |
| 2021 | $4,168 | 6 | AbbVie Inc. ($3,871) |
| 2020 | $2,466 | 3 | AbbVie Inc. ($2,466) |
| 2019 | $11,664 | 9 | AbbVie, Inc. ($11,664) |
| 2018 | $24,886 | 30 | AbbVie, Inc. ($22,289) |
| 2017 | $39,592 | 39 | PFIZER INC. ($17,253) |
All Payment Transactions
109 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $127.00 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $7.91 | General |
| Category: Immunology | ||||||
| 11/09/2023 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $90.26 | General |
| Category: IMMUNOLOGY | ||||||
| 10/17/2023 | Janssen Biotech, Inc. | TREMFYA (Drug), STELARA | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 09/14/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $52.42 | General |
| Category: IMMUNOLOGY | ||||||
| 06/08/2023 | AbbVie Inc. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $88.90 | General |
| Category: IMMUNOLOGY | ||||||
| 05/15/2023 | Fresenius Kabi USA, LLC | IDACIO (Biological) | Consulting Fee | Cash or cash equivalent | $610.00 | General |
| Category: Biosimilars | ||||||
| 03/09/2023 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $56.14 | General |
| Category: Immunology | ||||||
| 10/27/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $90.84 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $90.68 | General |
| Category: IMMUNOLOGY | ||||||
| 09/01/2022 | Lilly USA, LLC | — | Consulting Fee | Cash or cash equivalent | $5,625.00 | General |
| 08/18/2022 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $361.21 | General |
| 08/18/2022 | Lilly USA, LLC | — | Travel and Lodging | In-kind items and services | $177.00 | General |
| 08/18/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $127.00 | General |
| 08/18/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $60.00 | General |
| 08/18/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $45.00 | General |
| 08/18/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $34.00 | General |
| 08/18/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 08/18/2022 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.00 | General |
| 05/31/2022 | Takeda Pharmaceuticals U.S.A., Inc. | GATTEX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| Category: INTERNAL MEDICINE | ||||||
| 05/22/2022 | Cook Medical LLC | FUSION QUATTRO (Device) | Food and Beverage | Cash or cash equivalent | $44.47 | General |
| Category: Endoscopy | ||||||
| 04/07/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $79.09 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $116.95 | General |
| Category: Neuroscience | ||||||
| 10/21/2021 | E.R. Squibb & Sons, L.L.C. | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $90.91 | General |
| Category: Neuroscience | ||||||
| 08/25/2021 | AbbVie Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,375.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2 MULTICENTER RANDOMIZED PARALLEL-ARM PLACEBO-CONTROLLED STUDY OF LY3074828 IN SUBJECTS WITH ACTIVE CROHNS DISEASE (SERENITY) | Eli Lilly and Company | $6,123 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 178 | 215 | $98,170 | $21,961 |
| 2022 | 6 | 166 | 183 | $86,475 | $19,487 |
| 2021 | 6 | 176 | 194 | $86,587 | $20,209 |
| 2020 | 7 | 191 | 206 | $96,834 | $18,460 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 31 | 31 | $27,931 | $6,211 | 22.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 89 | $19,135 | $6,139 | 32.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 27 | 27 | $19,143 | $3,082 | 16.1% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 14 | 14 | $9,170 | $2,414 | 26.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $8,976 | $2,074 | 23.1% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $7,320 | $1,255 | 17.2% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 14 | 15 | $6,495 | $785.81 | 12.1% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 30 | 30 | $27,030 | $5,644 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 44 | 61 | $13,115 | $4,186 | 31.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 38 | $14,212 | $3,936 | 27.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 22 | 22 | $15,598 | $2,133 | 13.7% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2022 | 12 | 12 | $7,860 | $1,960 | 24.9% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 20 | 20 | $8,660 | $1,627 | 18.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 54 | 55 | $20,570 | $5,764 | 28.0% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 23 | 24 | $21,624 | $4,379 | 20.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 61 | $13,115 | $4,306 | 32.8% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 19 | 19 | $13,471 | $2,363 | 17.5% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 23 | 23 | $9,959 | $1,882 | 18.9% |
| 45378 | Diagnostic examination of the colon (large bowel) using an endoscope(colonoscopy); high risk | Facility | 2021 | 12 | 12 | $7,848 | $1,515 | 19.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 51 | 52 | $17,273 | $5,337 | 30.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope | Facility | 2020 | 26 | 26 | $29,606 | $4,971 | 16.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 50 | 62 | $12,420 | $3,148 | 25.3% |
| 45380 | Biopsy of large bowel using an endoscope | Facility | 2020 | 17 | 17 | $16,958 | $1,748 | 10.3% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 22 | 22 | $14,154 | $1,508 | 10.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 13 | 13 | $4,023 | $1,184 | 29.4% |
About Dr. Richard Bloomfeld, MD
Dr. Richard Bloomfeld, MD is a Gastroenterology healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194700534.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Richard Bloomfeld, MD has received a total of $90,825 in payments from pharmaceutical and medical device companies, with $134.91 received in 2024. These payments were reported across 109 transactions from 12 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($56,150).
As a Medicare-enrolled provider, Bloomfeld has provided services to 711 Medicare beneficiaries, totaling 798 services with total Medicare billing of $80,117. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Winston Salem, NC
- Active Since 12/08/2005
- Last Updated 07/16/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1194700534
Products in Payments
- XELJANZ (Drug) $5,635
- STELARA (Biological) $5,078
- Humira (Biological) $2,468
- IDACIO (Biological) $610.00
- RINVOQ (Biological) $311.09
- TREMFYA (Drug) $234.90
- ZEPOSIA (Drug) $207.86
- SKYRIZI (Biological) $181.10
- GATTEX (Drug) $150.00
- COOK MEDICAL BILIARY (Device) $138.53
- INFLECTRA (Biological) $76.22
- FUSION QUATTRO (Device) $44.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Winston Salem
Andrew Storm, M.d, M.D
Gastroenterology — Payments: $333,365
Kenneth Koch, Md, MD
Gastroenterology — Payments: $89,401
Herbert Bonkovsky, Md, MD
Gastroenterology — Payments: $69,085
Girish Mishra, Md, MD
Gastroenterology — Payments: $30,056
Dr. Christopher Connolley, M.d, M.D
Gastroenterology — Payments: $21,435
John Evans, Md, MD
Gastroenterology — Payments: $11,042